Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.
The item "Operating-Profit-Margin" stands at 43.86 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Operating Profit Margin" stands at 43.86 Percent. This represents an increase of 0.9 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.41 percentage points compared to the value the year prior.
The 1 year change in percentage points is 7.41.
The 3 year change in percentage points is 13.37.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Operating Profit Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Profit Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Profit Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Profit Margin | 280,205,508,085.11 |
![]() | Novartis AG - Operating Profit Margin | 255,096,620,580.91 |